Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.

Graziadei IW, Zoller HM, Schloegl A, Nachbaur K, Pfeiffer KP, Mark W, Mikuz G, Pratschke J, Margreiter R, Vogel W.

Liver Transpl. 2012 Jun;18(6):671-9. doi: 10.1002/lt.23402.

PMID:
22298465
[PubMed - indexed for MEDLINE]
Free Article
2.

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.

Eurich D, Boas-Knoop S, Ruehl M, Schulz M, Carrillo ED, Berg T, Neuhaus R, Neuhaus P, Neumann UP, Bahra M.

Liver Transpl. 2011 Mar;17(3):289-98. doi: 10.1002/lt.22235.

PMID:
21384511
[PubMed - indexed for MEDLINE]
Free Article
3.

Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.

Duarte-Rojo A, Budhraja V, Veldt BJ, Goldstein DD, Watt KD, Heimbach JK, McHutchison JG, Tillman HL, Poterucha JJ, Charlton MR.

Liver Transpl. 2013 Dec;19(12):1311-7. doi: 10.1002/lt.23733. Review.

PMID:
24039107
[PubMed - indexed for MEDLINE]
4.

CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.

Firpi RJ, Dong H, Clark VC, Soldevila-Pico C, Morelli G, Cabrera R, Norkina O, Shuster JJ, Nelson DR, Liu C.

Liver Int. 2013 Jan;33(1):72-8. doi: 10.1111/liv.12013. Epub 2012 Oct 29.

PMID:
23107586
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.

Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P.

Transplantation. 2012 May 27;93(10):1038-44. doi: 10.1097/TP.0b013e31824df7f3.

PMID:
22495472
[PubMed - indexed for MEDLINE]
6.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Hepatol. 2011 Apr;54(4):716-22. doi: 10.1016/j.jhep.2010.07.019. Epub 2010 Sep 19.

PMID:
21146242
[PubMed - indexed for MEDLINE]
7.

The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.

Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR.

Transplantation. 2012 Jul 27;94(2):197-203. doi: 10.1097/TP.0b013e3182547551.

PMID:
22766768
[PubMed - indexed for MEDLINE]
8.

Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4.

Rivero-Juárez A, Camacho Espejo A, Perez-Camacho I, Neukam K, Caruz A, Mira JA, Mesa P, García-Lázaro M, Torre-Cisneros J, Pineda JA, Rivero A.

J Antimicrob Chemother. 2012 Jan;67(1):202-5. doi: 10.1093/jac/dkr439. Epub 2011 Oct 11.

PMID:
21990051
[PubMed - indexed for MEDLINE]
Free Article
9.

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, Fumolo E, Bignulin S, Fontanini E, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Clin Immunol. 2011 Oct;31(5):891-9. doi: 10.1007/s10875-011-9547-1. Epub 2011 Jun 7.

PMID:
21647799
[PubMed - indexed for MEDLINE]
10.

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.

Lange CM, Moradpour D, Doehring A, Lehr HA, Müllhaupt B, Bibert S, Bochud PY, Antonino AT, Pascual M, Farnik H, Shi Y, Bechstein WO, Moench C, Hansmann ML, Sarrazin C, Lötsch J, Zeuzem S, Hofmann WP.

J Hepatol. 2011 Aug;55(2):322-7. doi: 10.1016/j.jhep.2010.10.037. Epub 2010 Dec 13.

PMID:
21147186
[PubMed - indexed for MEDLINE]
11.

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.

Huang CF, Huang JF, Yang JF, Hsieh MY, Lin ZY, Chen SC, Wang LY, Juo SH, Chen KC, Chuang WL, Kuo HT, Dai CY, Yu ML.

J Hepatol. 2012 Jan;56(1):34-40. doi: 10.1016/j.jhep.2011.03.029. Epub 2011 May 19. Erratum in: J Hepatol. 2012 May;56(5):1218.

PMID:
21703176
[PubMed - indexed for MEDLINE]
12.

Interleukin-28B polymorphism in hepatitis C and liver transplantation.

Duarte-Rojo A, Deneke MG, Charlton MR.

Liver Transpl. 2013 Jan;19(1):49-58. doi: 10.1002/lt.23554.

PMID:
23008132
[PubMed - indexed for MEDLINE]
13.

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.

Ackefors M, Nyström J, Wernerson A, Gjertsen H, Sönnerborg A, Weiland O.

J Viral Hepat. 2013 Nov;20(11):770-8. doi: 10.1111/jvh.12099. Epub 2013 Apr 23.

PMID:
24168256
[PubMed - indexed for MEDLINE]
14.

Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.

Liu CH, Liang CC, Liu CJ, Tseng TC, Lin CL, Yang SS, Su TH, Hsu SJ, Lin JW, Chen JH, Chen PJ, Chen DS, Kao JH.

Antivir Ther. 2012;17(3):477-84. doi: 10.3851/IMP2026. Epub 2011 Dec 20.

PMID:
22301466
[PubMed - indexed for MEDLINE]
15.

Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.

Ciccorossi P, Maina AM, Oliveri F, Petruccelli S, Leandro G, Colombatto P, Moriconi F, Mosca F, Filipponi F, Bonino F, Brunetto MR.

Liver Int. 2007 Jun;27(5):612-9.

PMID:
17498245
[PubMed - indexed for MEDLINE]
16.

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Bitetto D, De Feo T, Mantovani M, Falleti E, Fabris C, Belli LS, Fagiuoli S, Burra P, Piccolo G, Donato MF, Toniutto P; AISF RECOLT Study Group, Cmet S, Cussigh A, Viganò R, Airoldi A, Pasulo L, Colpanij M, De Martin E, Gambato M, Rigamonti C.

Dig Liver Dis. 2013 Nov;45(11):927-32. doi: 10.1016/j.dld.2013.04.006. Epub 2013 May 27.

PMID:
23722013
[PubMed - indexed for MEDLINE]
17.

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, Hiraga N, Kawakami Y, Aimitsu S, Kao JH, Kubo M, Tsunoda T, Kumada H, Nakamura Y, Hayes CN, Chayama K.

J Gen Virol. 2011 May;92(Pt 5):1071-81. doi: 10.1099/vir.0.029124-0. Epub 2011 Jan 12.

PMID:
21228123
[PubMed - indexed for MEDLINE]
Free Article
18.

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.

Mangia A, Thompson AJ, Santoro R, Piazzolla V, Tillmann HL, Patel K, Shianna KV, Mottola L, Petruzzellis D, Bacca D, Carretta V, Minerva N, Goldstein DB, McHutchison JG.

Gastroenterology. 2010 Sep;139(3):821-7, 827.e1. doi: 10.1053/j.gastro.2010.05.079. Epub 2010 Jun 2.

PMID:
20621700
[PubMed - indexed for MEDLINE]
19.

Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.

Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, Frilling A, Malago M, Gerken G, Broelsch CE, Beckebaum S.

Transplantation. 2007 Jul 15;84(1):56-63.

PMID:
17627238
[PubMed - indexed for MEDLINE]
20.

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Hashimoto Y, Ochi H, Abe H, Hayashida Y, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Nelson Hayes C, Ohishi W, Kubo M, Tsunoda T, Kamatani N, Nakamura Y, Chayama K.

J Med Virol. 2011 Jun;83(6):981-8. doi: 10.1002/jmv.22028.

PMID:
21503910
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk